Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
In conclusion, PEGylation of antigenic peptides is an effective and feasible strategy to improve Treg-inducing, peptide-based vaccines with potential use for the treatment of autoimmune diseases, allergies, and transplant rejection.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy | Allergy & Immunology | Autoimmune Disease | Clinical Trials | Nanotechnology | Polyethylene Glycol | Study | Transplants | Vaccines